GB1525425A - Sustained release forms of certain oxazepines - Google Patents

Sustained release forms of certain oxazepines

Info

Publication number
GB1525425A
GB1525425A GB26914/76A GB2691476A GB1525425A GB 1525425 A GB1525425 A GB 1525425A GB 26914/76 A GB26914/76 A GB 26914/76A GB 2691476 A GB2691476 A GB 2691476A GB 1525425 A GB1525425 A GB 1525425A
Authority
GB
United Kingdom
Prior art keywords
oxazepines
certain
oxazepine
sustained release
release forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB26914/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB1525425A publication Critical patent/GB1525425A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB26914/76A 1975-07-16 1976-06-28 Sustained release forms of certain oxazepines Expired GB1525425A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (1)

Publication Number Publication Date
GB1525425A true GB1525425A (en) 1978-09-20

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
GB26914/76A Expired GB1525425A (en) 1975-07-16 1976-06-28 Sustained release forms of certain oxazepines

Country Status (11)

Country Link
US (1) US4016273A (https=)
BE (1) BE844203A (https=)
CA (1) CA1062159A (https=)
DE (1) DE2630394A1 (https=)
DK (1) DK319776A (https=)
FI (1) FI762053A7 (https=)
FR (1) FR2317912A1 (https=)
GB (1) GB1525425A (https=)
NL (1) NL7607918A (https=)
PT (1) PT65358B (https=)
SE (1) SE7608114L (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
JP4361710B2 (ja) * 2000-04-19 2009-11-11 ジェネンテック・インコーポレーテッド 徐放製剤
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
AU2002320122B2 (en) * 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
BRPI0418304A (pt) * 2004-01-07 2007-05-02 Trimeris Inc peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv
PL1838716T3 (pl) * 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
US7456251B2 (en) * 2006-02-02 2008-11-25 Trimeris, Inc. HIV fusion inhibitor peptides with improved biological properties
ES2346005T3 (es) * 2006-07-27 2010-10-07 Cognis Ip Management Gmbh Procedimiento para la obtencion de glicerina.
BRPI0809995A2 (pt) * 2007-04-03 2015-07-21 Trimeris Inc Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
KR20100080812A (ko) * 2007-09-25 2010-07-12 트라이머리스, 인코퍼레이티드 치료용 항-ｈｉｖ 펩티드의 합성 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Also Published As

Publication number Publication date
BE844203A (fr) 1977-01-17
PT65358B (en) 1978-01-09
DE2630394A1 (de) 1977-02-03
PT65358A (en) 1976-08-01
SE7608114L (sv) 1977-01-17
NL7607918A (nl) 1977-01-18
US4016273A (en) 1977-04-05
FR2317912B1 (https=) 1979-04-13
CA1062159A (en) 1979-09-11
DK319776A (da) 1977-01-17
FI762053A7 (https=) 1977-01-17
FR2317912A1 (fr) 1977-02-11

Similar Documents

Publication Publication Date Title
GB1525425A (en) Sustained release forms of certain oxazepines
ATE274601T1 (de) Elektroerzeugte chemilumineszierende markierungsmittel zur analyse und/oder zur referenzbildung
CA2008169A1 (en) Hollow drilling tool
ES2074457T3 (es) Procedimiento para la determinacion colorimetrica de un analito mediante oxidacion enzimatica.
PE38897A1 (es) Solucion acuosa de interferon alfa
HUT77716A (hu) Eljárás 4a,5,9,10,11,12-hexahidro-6H-benzofuro[3a,3,2ef][2]-benzazepin-származékok előállítására, és egyes ilyen vegyületek
YU40891A (sh) Podloga za kontrastno sredstvo
MX9303376A (es) Utilizacion de metilhidroxietil- o metilhidroxipropil-(eteres de celulosa)carboximetilados.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
AR001432A1 (es) Cilindro y horquilla de cambio.
ATE94396T1 (de) N-acetylneuraminsaeure enthaltende expektorantien.
ES2114086T3 (es) Composicion grasa a base de urea.
NZ505821A (en) Pharmaceutical compositions of uridine triphosphate
AU557922B2 (en) Scabber bit
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
TR27311A (tr) Maddelerin erimis bir banyo icine sokulmasi icin ocak hamlaci düzenegi ve bu tür bir ocak hamlaci düzeneginin calistirilmasi icin bir yöntem.
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
MX168339B (es) Conversion del metano
ES2037838T3 (es) Derivados de eritromicina a modificados en c-12.
ES2059403T3 (es) Composicion util en el tratamiento de deficiencias de estrogenos.
DE69415812D1 (de) 15,15-dialkylsubstituierte östradiolderivate
HU904426D0 (en) 8-alpha-acyl-amino-ergoline derivatives and their utilization as medicament
NZ334087A (en) 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives
IT8021211A0 (it) Cappello decorativo per viti adatte per l'assemblaggio di mobili.
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee